MedTrace Logo

Orthorexia Nervosa in Fibromyalgia

NCT06947200 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 84

Last updated 2025-04-27

No results posted yet for this study

Summary

This clinical cross-sectional study will include 84 female patients aged between 18 and 65 years who have been diagnosed with fibromyalgia syndrome according to the 2010 American College of Rheumatology diagnostic criteria. Sociodemographic data will be recorded at the beginning of the study. Pain severity will be assessed using the Visual Analog Scale (VAS). Orthorexia nervosa-related symptoms will be evaluated with the ORTO-11 scale. Body image will be assessed with the Body Appreciation Scale 2, mood will be evaluated using the Hospital Anxiety and Depression Scale (HADS), and fibromyalgia-related impact will be assessed with the Fibromyalgia Impact Questionnaire (FIQ).

Conditions

  • Fibromyalgia

Interventions

OTHER

Fibromyalgia

no intervention

Sponsors & Collaborators

  • Beylikduzu State Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-20
Primary Completion
2025-05-20
Completion
2025-05-20

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06947200 on ClinicalTrials.gov